P1226 NS3 Q80K DID NOT IMPACT EFFICACY OR TREATMENT-EMERGENT RESISTANCE PATTERNS IN HCV GENOTYPE 1-INFECTED PATIENTS RECEIVING FALDAPREVIR + PEGINTERFERON/RIBAVIRIN IN THREE PHASE III TRIALS

✍ Scribed by Berger, K.; Sarrazin, C.; Ferenci, P.; Jensen, D.M.; Jacobson, I.M.; Stern, J.O.; Quinson, A.-M.; Scherer, J.; Kukolj, G.

• Book ID: 122312706
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 59 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)61386-6